SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CRESCENT BIOPHARMA - Q3 NET LOSS WAS $37.70 MLN, OR $0.9 PER SHARE

CBIO

Related stories